TD Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,692
| Closed | -$844K | – | 1406 |
|
|
2024
Q1 | $844K | Hold |
30,692
| – | – | ﹤0.01% | 1202 |
|
|
2023
Q4 | $936K | Sell |
30,692
-18,200
| -37% | -$555K | ﹤0.01% | 1189 |
|
|
2023
Q3 | $1.55M | Buy |
48,892
+24,446
| +100% | +$773K | ﹤0.01% | 1030 |
|
|
2023
Q2 | $997K | Sell |
24,446
-5,325
| -18% | -$217K | ﹤0.01% | 1133 |
|
|
2023
Q1 | $1.11M | Sell |
29,771
-19,678
| -40% | -$733K | ﹤0.01% | 1111 |
|
|
2022
Q4 | $1.73M | Buy |
49,449
+4,178
| +9% | +$146K | ﹤0.01% | 1031 |
|
|
2022
Q3 | $2.5M | Buy |
45,271
+394
| +0.9% | +$21.8K | ﹤0.01% | 931 |
|
|
2022
Q2 | $2.32M | Sell |
44,877
-6,418
| -13% | -$332K | ﹤0.01% | 966 |
|
|
2022
Q1 | $3.73M | Sell |
51,295
-6,254
| -11% | -$455K | ﹤0.01% | 897 |
|
|
2021
Q4 | $6.81M | Buy |
57,549
+2,719
| +5% | +$322K | 0.01% | 787 |
|
|
2021
Q3 | $7.36M | Sell |
54,830
-1,100
| -2% | -$148K | 0.01% | 728 |
|
|
2021
Q2 | $7.93M | Buy |
55,930
+4,451
| +9% | +$631K | 0.01% | 712 |
|
|
2021
Q1 | $4.13M | Buy |
51,479
+5,250
| +11% | +$421K | ﹤0.01% | 884 |
|
|
2020
Q4 | $2.52M | Buy |
46,229
+7,372
| +19% | +$401K | ﹤0.01% | 975 |
|
|
2020
Q3 | $772K | Buy |
38,857
+4,300
| +12% | +$85.4K | ﹤0.01% | 1136 |
|
|
2020
Q2 | $726K | Buy |
+34,557
| New | +$726K | ﹤0.01% | 1135 |
|